Flagship Harbor Advisors’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-445
Closed -$22K 996
2020
Q3
$22K Sell
445
-302
-40% -$15.6K ﹤0.01% 1104
2020
Q2
$35K Buy
747
+302
+68% +$14.6K 0.01% 954
2020
Q1
$19K Hold
445
﹤0.01% 1040
2019
Q4
$26K Hold
445
﹤0.01% 1028
2019
Q3
$22K Hold
445
﹤0.01% 1051
2019
Q2
$18K Sell
445
-60
-12% -$2.61K ﹤0.01% 1115
2019
Q1
$24K Hold
505
﹤0.01% 1003
2018
Q4
$21K Sell
505
-394
-44% -$19.7K 0.01% 998
2018
Q3
$50K Buy
899
+120
+15% +$6.32K 0.01% 798
2018
Q2
$39K Buy
+779
New +$40.6K 0.01% 869

Other funds holding GMED

Flagship Harbor Advisors's GMED Position: Q4 2020 in Review

Flagship Harbor Advisors sold out of Globus Medical (GMED) in Q4 2020, closing a stake of 445 shares — an estimated $22K sold.

Flagship Harbor Advisors first reported a position in GMED in Q2 2018 and held it in 10 quarters. The position peaked at $50K in Q3 2018. 348 funds tracked by Wall St. Rank hold GMED as of Q4 2020.

  • Flagship Harbor Advisors reported no remaining Globus Medical position as of Q4 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 445 Globus Medical shares in Q4 2020, an estimated $22K.
  • Flagship Harbor Advisors first reported a position in Globus Medical in Q2 2018 and held it in 10 quarters.
  • Flagship Harbor Advisors's Globus Medical position peaked at $50K in Q3 2018.
  • 348 funds tracked by Wall St. Rank held Globus Medical as of Q4 2020.

Based on Flagship Harbor Advisors's 13F filing for Q4 2020, filed 8 Feb 2021.